“Bloodtest with Great Potential” in health magazine

Wed May 11 2016

The Danish health-magazine Helse has in their May edition an article on suPAR and its great potential;
“Blodtest med Store Perspektiver” – see link here (in Danish).

The article talks about suPAR and its ability to find different diseases even before the patient is ill, and also its potential to help patients take preventive actions if they see that their suPAR level is too high – and thus live a more healthy life with more physical activity, more healthy diet, less smoking etc. – to bring their suPAR level down.

Dr. Jesper Eugen-Olsen is interviewed and talks about the biomarkers routine use in Hvidovre Hospital, Denmark.

Dr. Martin Schultz talks about the big TRIAGE III study being caried out at the moment, a randomised multicentre intervention study where 10.000 patients will be suPAR measured at different hospitals in the Copenhagen region from January – June 2016.


published suPAR studies in leading medical journals

Nature Medicine Logo
Science Journal Logo
JAMA Pediatrics Logo

The suPARnostic® brand consists of 3 products:

Quick Triage

A Point of Care Solution


For Automated Systems


Clinical and Research

suPAR is used in clinical routine in 48 hospitals

48 hospitals use suPAR in clinical routine for triage of patients in the Emergency Departments and COVID-19 units. Clinical routine is defined by the placement of two Purchasing Orders within the last 12 months rolling.
This period covers January 1, 2022, until December 31, 2022. Some hospital locations cannot be disclosed due to confidentiality.

New Webinar


Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates